We have developed a specific, sensitive, and quantitative assay for topoisomerase I, which is based on the formation of a covalent enzyme-DNA intermediate. Our assay measures the quantitative transfer of 32P radioactivity from 32P-labeled DNA to topoisomerase I. Since 32P-labeled topoisomerase molecules are resolved by NaDodSO4/PAGE, HeLa topoisomerase I (100 kDa) and calf thymus topoisomerase I (82 kDa) can be quantitatively assayed in the same reaction mixture. The assay can detect at least 0.3 ng (3 fmol) of topoisomerase I. We have used our assay to measure the levels of topoisomerase I activity in crude extracts of nuclei prepared from uninfected, adenovirus-infected, and adenovirus-transformed human cells. The evidence suggests that an adenovirus early gene product, presumably a protein encoded in early region 1A (ElA), increases cellular topoisomerase I activity at least 10-fold. Immunoblotting analysis with antiserum against calf thymus topoisomerase I shows that the increase in activity is due to an increase in the amount of enzyme.
32P-labeled DNA to topoisomerase I. Since 32P-labeled topoisomerase molecules are resolved by NaDodSO4/PAGE, HeLa topoisomerase I (100 kDa) and calf thymus topoisomerase I (82 kDa) can be quantitatively assayed in the same reaction mixture. The assay can detect at least 0.3 ng (3 fmol) of topoisomerase I. We have used our assay to measure the levels of topoisomerase I activity in crude extracts of nuclei prepared from uninfected, adenovirus-infected, and adenovirus-transformed human cells. The evidence suggests that an adenovirus early gene product, presumably a protein encoded in early region 1A (ElA), increases cellular topoisomerase I activity at least 10-fold. Immunoblotting analysis with antiserum against calf thymus topoisomerase I shows that the increase in activity is due to an increase in the amount of enzyme.
Topoisomerases alter the topological properties of DNA molecules (1, 2) . Type I topoisomerases change the linking number of covalently closed circular DNA in steps of 1 by introducing single-strand breaks (3) , and type II topoisomerases, in steps of 2 by catalyzing double-strand breaks (4) (5) (6) . We have developed a specific, sensitive, and quantitative assay for topoisomerase I based on the formation of a covalent enzyme-DNA intermediate (7) (8) (9) (10) (11) (12) (13) (14) . In the case of eukaryotic type I topoisomerases, the cycle of strand breakage and reunion proceeds through an energy-conserving intermediate in which the linkage is between a tyrosine residue on the enzyme (14) and a 3'-phosphoryl residue at the cleavage site (7, (11) (12) (13) . Our assay measures the transfer of 32p from 32p-labeled DNA to topoisomerase I. Since 32P-labeled topoisomerase molecules are identified by NaDodSO4/PAGE, HeLa topoisomerase I (100 kDa) and calf thymus topoisomerase I (82 kDa) can be quantitatively assayed in the same reaction mixture. The assay can detect at least 0.3 ng (3 fmol) of topoisomerase I.
We have used our assay to measure the levels of topoisomerase I activity in crude extracts of nuclei prepared from uninfected, adenovirus-infected, and adenovirus-transformed human cells. The evidence, although circumstantial, suggests that an adenovirus early gene product, presumably a protein encoded in early region 1A (ElA), increases cellular topoisomerase I activity at least 10-fold. Further analysis by immunoblotting shows that the increase in activity corresponds to an increase in the amount of topoisomerase I. ElA expression facilitates the efficient transcription of other adenovirus genes (15) (16) (17) , activates the transcription of the human heat-shock gene (18, 19) but not cellular genes in general, stimulates the transcription of genes newly introduced into cells by transfection (20, 21) or viral infection (22) , and eliminates the cis-requirement for enhancers on transfected genes (20, 21) . It is tempting to conclude that, as in the case of the human heat-shock gene (18, 19) 15 min at 37°C, the dCTP concentration was adjusted to 50 ,M and incubation was continued for another 15 min; 600-2000 nucleotides were polymerized under these conditions. The reaction then was heated for 5 min at 650C, the volume of the solution was adjusted to 100 ,l with STE buffer (100 mM NaCl/10 mM Tris Cl, pH 7.5/1 mM EDTA), and 32P-labeled DNA was separated from unincorporated nucleotides by chromatography on Sephadex G-75. DNA was precipitated with ethanol and dissolved at a concentration of 250 ,g/ml in TE buffer (10 mM Tris Cl, pH 7.5/1 mM EDTA).
Topoisomerase Reaction. Nuclear and cytoplasmic extracts were prepared from uninfected and adenovirus-infected HeLa cells and from the adenovirus-transformed human embryonic kidney cell line 293 as described (25) . The protein concentration in the nuclear extracts ranged from 4 to 6 mg/ml, and the concentration in the cytoplasmic extracts varied from 14 to 17 mg/ml. The The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. or purified topoisomerase I instead of nuclear extract. After incubation for 30 min at 37TC, DNase I was added at a concentration of 100 ug/ml, and the incubation was continued for 10 min. The reaction was stopped by adding an equal volume of double-strength Laemmli sample buffer (26) and heating at 100'C for 5 min. Samples digested with Pronase prior to gel electrophoresis were first inactivated by heating for 5 min at 650C after DNase I treatment, adjusted to 0.1% NaDodSO4, and then incubated with Pronase at a concentration of 1 mg/ml for 1 hr at 37TC.
Gel Electrophoresis. Gel electrophoresis was carried out at 120 V for 2 hr in 10% polyacrylamide gels containing 0.1% NaDodSO4 (10 cm wide x 8 cm long x 0.8 mm thick). The stacking gel contained 6% polyacrylamide and 0.1% NaDodSO4. The electrophoresis buffer was 50 mM Tris borate, pH 8.3/1 mM EDTA/0.1% NaDodSO4. After fixation with 50% (vol/vol) methanol and staining with AgNO3, the gels were dried and autoradiographed. Autoradiograms were scanned with a'Zeineh SL-504-XL soft-laser densitometer and band intensities were integrated by using an electrophoresis reporting integrator program (Biomed).
RESULTS
Assay of Topoisomerase I. The strategy for assay of topoisomerase I is detailed in Fig. 1 . The assay measures the transfer of 32P radioactivity from 32P-labeled DNA to topoisomerase I. Central to the scheme is the observation that eukaryotic topoisomerase I forms a covalent intermediate with DNA where the linkage is between a tyrosine residue on the enzyme (14) and a 3'-phosphoryl group at the cleavage site (7, (11) (12) (13) . The covalent intermediate can be trapped by digesting DNA with DNase I. After NaDodSO4/PAGE, the resulting 32P-labeled topoisomerase I molecules can be detected by autoradiography. tracts (25, 27, 28) (14) and a 3'-phosphoryl residue at the cleavage site (7, (11) (12) (13) Fig. 2 also shows that the 100-kDa topoisomerase I band was labeled to a 10-fold greater extent in the reaction with nuclear extract from adenovirus-infected cells even though the total protein concentration in both extracts was identical. This difference was not due to leakage during the isolation of nuclei, since no topoisomerase I activity was observed in cytoplasmic extracts from either adenovirus-infected or uninfected HeLa cells (data not shown). Since the activity of purified HeLa topoisomerase I could be detected when added to either cytoplasmic extract (data not shown), the cytoplasmic extracts did not contain an inhibitor of the enzyme. Moreover, the nuclear extract from uninfected cells did not contain an enzyme inhibitor (see Fig. 6 ).
Quantitation of Topoisomerase I. Purified calf thymus topoisomerase I (Mr 82,000) was reacted with 32P-labeled DNA substrate. Fig. 3 shows that when the calf thymus enzyme was assayed alone (lanes 8-12) , only the two highest concentrations of the serial dilution showed activity. However, when the purified enzyme was diluted into reaction mixtures containing nuclear extract from adenovirus-infected cells, activity could easily be detected down to the lowest concentration (lanes 3-7). The extent of labeling of the 82-kDa topoisomerase I in each reaction was determined by quantitative densitometry. Fig. 4 shows that the labeling was stoichiometric; the intensity of each band was linearly proportional to the amount of added enzyme. The labeling of topoisomerase I was constant with time of incubation (data not shown) and likely reflects the instantaneous fraction of enzyme in the covalent intermediate state during the overall nicking-closing reaction (31) . This fraction corresponds to 4% of the enzyme molecules for rat liver topoisomerase I (11) . Fig. 3 also shows that calf thymus topoisomerase I, even when added in 300-fold molar excess, did not interfere with the activity of the endogenous HeLa topoisomerase I. Quantitative densitometry established that the intensity of each 100-kDa HeLa enzyme band in lanes 3-7 was identical to the intensity of that band in lane 2 where no calf thymus enzyme had been added. Interestingly, human topoisomerase I was labeled to the same extent in nuclear extracts from cells of the adenovirus-transformed human cell line 293 1 and 2) . This result will be discussed below.
The relative amounts of topoisomerase I in nuclear extracts from uninfected and adenovirus-infected HeLa cells were independently measured by an immunoblotting assay (33, 34) . Nuclear extracts were fractionated by polyacrylamide gel electrophoresis, and the proteins were transferred from the gel to a nitrocellulose membrane. HeLa topoisomerase I was detected by using cross-reacting antiserum against calf thymus topoisomerase I followed by 125I-labeled protein A. A 100-kDa band was visualized in each nuclear extract (Fig. 5) . Quantitative densitometry revealed that the band in the extract from adenovirus-infected cells was 10-fold more intense than the band in the nuclear extract from --l oo kDa 1 2 FIG. 5. Quantitation of topoisomerase I levels by immunoblotting with antiserum against calf thymus topoisomerase I. After electrophoresis, gels were soaked for 1 hr in 10 mM Tris Cl, pH 7.4/50 mM NaCI/2 mM EDTA/0.1 mM dithiothreitol/4 M urea. Proteins were transferred from gels to nitrocellulose membranes by immersion for 24 hr in the same buffer lacking urea. After transfer, membranes were soaked for 2 hr in P1/NaCl (10 mM sodium phosphate buffer, pH 7.4/100 mM NaCl) with 5% bovine serum albumin and then rinsed with PJ/NaCl alone. Membranes were incubated overnight at 4°C with antiserum against calf thymus topoisomerase I (diluted 1:500 into Pi/NaCl containing 5% bovine serum albumin), washed twice with Pi/NaCl containing 0.05% Nonidet P-40, and rinsed once with P,/NaCl alone. Immunocomplexes were reacted with protein A by incubating membranes at 4°C for 4 hr with 125I-labeled protein A (=105 cpm/ml in P1/NaCl containing 5% bovine serum albumin). After two rinses with P1/NaCl containing 0.05% Nonidet P-40 and one rinse with Pi/NaCl alone, membranes were dried and autoradiographed. Lane 1: nuclear extract from uninfected HeLa cells. Lane 2: nuclear extract from adenovirus-infected HeLa cells.
Biochemistry: Chow and Pearson 2250 Biochemistry: Chow and Pearson uninfected cells. This result correlates elevated topoisomerase I activity with an increase in the number of enzyme molecules (also see Fig. 6 ).
We have used purified calf thymus enzyme (or purified HeLa enzyme, see below) as an internal standard to calculate the number of topoisomerase I molecules in nuclear extracts. (35) . We estimate that the assay can detect at least 0.3 ng (3 fmol) of topoisomerase I.
Identification of Topoisomerase I. Topoisomerase I activity is heat-sensitive. Nuclear extracts from uninfected and adenovirus-infected HeLa cells were incubated at 60'C for various periods of time prior to assay for topoisomerase I activity. Endogenous topoisomerase I was totally inactivated by heating either extract for 10 min or longer (data not shown). To demonstrate that the enzyme in nuclear extracts was identical to HeLa topoisomerase I, we diluted purified HeLa topoisomerase I into heat-inactivated nuclear extracts from uninfected HeLa cells and then assayed the topoisomerase activity. The results are shown in Fig. 6 . Purified HeLa topoisomerase I appeared as a 100-kDa band (lanes 3 (27) . Moreover, HeLa topoisomerase I activity increased by 6 hr after infection (data not shown), before the onset of late-gene expression. Finally, we found high levels of topoisomerase I activity in line 293 cells (Fig. 3) , adenovirus-transformed human cells that express adenovirus ElA and E1B genes (37 (Fig. 1) , is (i) simple: topoisomerase I activity can be measured in crude nuclear extracts; (it) specific: topoisomerase I is the only protein labeled in nuclear extracts (Fig. 2) (Fig. 5) . The ElA region is the first to be transcribed upon adenovirus infection, and efficient transcription of the remaining viral genes requires one of the ElA gene products (15) (16) (17) . ElA expression also induces the transcription of the human heat-shock gene (18, 19) , activates the transcription of exogenous genes in trans (20) (21) (22) , and overcomes the cis-requirement for enhancer or activator sequences in transient-expression assays (20, 21 (40) . In fact, the requirement for nuclear factor II can be totally satisfied by purified HeLa or calf thymus topoisomerase I but not E. coli topoisomerase I (40) . The increase in topoisomerase I activity in adenovirus-infected cells may, therefore, represent an example of viral induction of a cellular factor that is required for viral DNA replication.
